BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 28275110)

  • 41. The pharmacokinetics and pharmacodynamics of progastrin-derived peptides.
    Hansen CP
    Dan Med Bull; 2003 Nov; 50(4):310-9. PubMed ID: 14694849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of neurotensin and neurotensin fragments on gastric acid secretion in man.
    Holst Pedersen J; Skov Olsen P; Kirkegaard P
    Regul Pept; 1986 Aug; 15(1):77-86. PubMed ID: 3763961
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholecystokinin is a physiological regulator of gastric acid secretion in man.
    Burckhardt B; Delco F; Ensinck JW; Meier R; Bauerfeind P; Aufderhaar U; Ketterer S; Gyr K; Beglinger C
    Eur J Clin Invest; 1994 Jun; 24(6):370-6. PubMed ID: 7957488
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An analysis of the effects of galanin on gastric acid secretion and plasma levels of gastrin in the dog.
    Soldani G; Mengozzi G; Della Longa A; Intorre L; Martelli F; Brown DR
    Eur J Pharmacol; 1988 Sep; 154(3):313-8. PubMed ID: 2466671
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The fade of gastrin-stimulated gastric acid secretion in the rat is due to depletion of releasable mucosal histamine.
    Rønning K; Sandvik AK; Waldum HL
    Acta Physiol Scand; 1996 Aug; 157(4):487-91. PubMed ID: 8869732
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypergastrinemia is associated with decreased gastric acid secretion in 2,3,7,8-tetrachlorodibenzo-p-dioxin-treated rats.
    Mably TA; Theobald HM; Ingall GB; Peterson RE
    Toxicol Appl Pharmacol; 1990 Dec; 106(3):518-28. PubMed ID: 2260098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of loxiglumide on basal and gastrin- and bombesin-stimulated gastric acid and serum gastrin levels.
    Jebbink MC; Lamers CB; Mooy DM; Rovati LC; Jansen JB
    Gastroenterology; 1992 Oct; 103(4):1215-20. PubMed ID: 1397878
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reversal by omeprazole of the depression of gastrin cell function by fasting in the rat.
    Dimaline R; Evans D; Varro A; Dockray GJ
    J Physiol; 1991 Feb; 433():483-93. PubMed ID: 1841954
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Naming progastrin-derived peptides.
    Rehfeld JF; Bundgaard JR; Goetze JP; Friis-Hansen L; Hilsted L; Johnsen AH
    Regul Pept; 2004 Aug; 120(1-3):177-83. PubMed ID: 15177936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum progastrin and its products, gastric acid secretion and serum pepsinogen I in gastric cancer.
    Konturek SJ; Konturek PC; Bielanski W; Karczewska E; Zuchowicz M; Hartwich A; Rehfeld JF; Goetze JP; Hahn EG
    Digestion; 2003; 68(4):169-77. PubMed ID: 14671424
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of peptide hormone structure on H+ secretion by Necturus gastric mucosa.
    Berkowitz JM; Praissman M; LeFevre ME
    Am J Physiol; 1976 Aug; 231(2):573-8. PubMed ID: 961910
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of ninety-five percent pure cholecystokinin on gastrin-stimulated acid secretion in man and dog.
    Corazziari E; Solomon TE; Grossman MI
    Gastroenterology; 1979 Jul; 77(1):91-5. PubMed ID: 447032
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Preparation of biologically active recombinant human progastrin(1-80).
    McQueen K; Kovac S; Ho PK; Rorison K; Pannequin J; Neumann G; Shulkes A; Baldwin GS
    J Protein Chem; 2002 Oct; 21(7):465-71. PubMed ID: 12523650
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of the 1-13 sequence of gastrin 17 in humans and failure to influence acid secretion.
    Pauwels S; Dockray GJ; Walker R; Marcus S
    Gastroenterology; 1985 Jul; 89(1):49-56. PubMed ID: 4007412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CCK1 and CCK2 receptors regulate gastric pepsinogen secretion.
    Blandizzi C; Lazzeri G; Colucci R; Carignani D; Tognetti M; Baschiera F; Del Tacca M
    Eur J Pharmacol; 1999 May; 373(1):71-84. PubMed ID: 10408253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolism of recombinant progastrin in sheep.
    Paterson AC; Baldwin GS; Shulkes A
    Am J Physiol Endocrinol Metab; 2002 Sep; 283(3):E449-56. PubMed ID: 12169437
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of posttranslational processing of gastrin precursor in dogs.
    Varro A; Nemeth J; Bridson J; Lonovics J; Dockray GJ
    Am J Physiol; 1990 Jun; 258(6 Pt 1):G904-9. PubMed ID: 2360636
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The gastric acid secretagogue gastrin-releasing peptide and the inhibitor oxyntomodulin do not exert their effect directly on the parietal cell in the rat.
    Gehl J; Jeppesen JL; Poulsen SS; Holst JJ
    Digestion; 1988; 40(3):144-51. PubMed ID: 3234620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice.
    Chen D; Zhao CM; Dockray GJ; Varro A; Van Hoek A; Sinclair NF; Wang TC; Koh TJ
    Gastroenterology; 2000 Sep; 119(3):756-65. PubMed ID: 10982770
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caloric restriction causes secretagogue specific changes of gastric acid secretion in rats.
    Higashide S; Chu KU; Gomez G; Greeley GH; Thompson JC; Townsend CM
    Regul Pept; 1997 Feb; 68(3):205-10. PubMed ID: 9100288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.